Haemophilus b Conjugate Vaccine (Systemic)
CategoryDescriptionHaemophilus b conjugate
(hem-OFF-fil-us BEE KON-ja-gat)
vaccine is an active immunizing agent used to prevent infection by Haemophilus influenza
type b (Hib) bacteria. The vaccine works
by causing your body to produce its own protection (antibodies) against the
disease.
Haemophilus b conjugate vaccine is an haemophilus b vaccine that has been
prepared by adding a diphtheria-, meningococcal-, or tetanus-related substance.
However, this vaccine does not
take the place
of the regular diphtheria or tetanus toxoid injections (for example, DTP,
DT, or T) that children should receive, the regular tetanus toxoid or diphtheria
and tetanus toxoid injections (for example T or Td) that adults should receive,
or the meningococcal vaccine injection that some children and adults should
receive.
Infection by Haemophilus influenza
type
b (Hib) bacteria can cause life-threatening illnesses, such as meningitis,
which affects the brain; epiglottitis, which can cause death by suffocation;
pericarditis, which affects the heart; pneumonia, which affects the lungs;
and septic arthritis, which affects the bones and joints. Hib meningitis causes
death in 5 to 10% of children who are infected. Also, approximately 30% of
children who survive Hib meningitis are left with some type of serious permanent
damage, such as mental retardation, deafness, epilepsy, or partial blindness.
Immunization against Hib is recommended for all children 2 months up to
5 years of age (i.e., up to the 5th birthday).
Immunization against Hib may also be recommended for adults and children
over 5 years of age with certain medical problems.
This vaccine is to be administered only by or under the supervision of
your doctor or other authorized health care professional. It is available
in the following dosage form:
Parenteral
-
Injection (U.S. and Canada)
Brand NamesSome commonly used brand names are:
In the U.S. -
- Act-Hib 4
- Hibtiter 1
- Pedvaxhib 3
- Prohibit 2
In Canada -
- Act-Hib 4
- Hibtiter 1
- Pedvaxhib 3
- Prohibit 2
Other commonly used names are: HbOC
,
PRP-D
, PRP-OMP
, and
PRP-T
.
| This information applies to the following medicines: |
| 1. |
Haemophilus b Conjugate Vaccine (HbOC - DiphtheriaCRM 197
Protein Conjugate)ठ|
| 2. |
Haemophilus b Conjugate Vaccine (PRP-D - DiphtheriaToxoid Conjugate)ठ|
| 3. |
Haemophilusb Conjugate Vaccine (PRP-OMP - Meningococcal Protein Conjugate)§ |
| 4. |
Haemophilus b Conjugate Vaccine (PRP-T - TetanusProtein Conjugate)ठ|
| ‡ Generic name product may be available
in the U.S. |
| § Generic name product may be available
in Canada |
|
